Stock-Based Compensation for Align Technology (ALGN)
Stock-Based Compensation for Align Technology (ALGN): headline value $271.79M · YoY -100.0%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
ALGN
Currently viewingStock-Based CompensationSwitch metric
Latest period
$271.79M
YoY change
-100.0%
5Y CAGR
-100.0%
Peak year (2024)
$173.70M
Latest annual
$0
Stock-Based Compensation history chart for Align Technology (ALGN) from 1999 to 2025
Stock-Based Compensation history table for Align Technology (ALGN) from 1999 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY | YoY change |
|---|---|---|---|---|---|
| 2025 | $0 | -100.0% | -$173.70M | ||
| 2024 | $173.70M | +12.8% | +$19.68M | ||
| 2023 | $154.03M | +15.5% | +$20.66M | ||
| 2022 | $133.37M | +16.6% | +$19.03M | ||
| 2021 | $114.34M | +16.2% | +$15.91M | ||
| 2020 | $98.43M | +11.6% | +$10.24M | ||
| 2019 | $88.18M | +24.6% | +$17.42M | ||
| 2018 | $70.76M | +20.2% | +$11.91M | ||
| 2017 | $58.85M | +8.7% | +$4.71M | ||
| 2016 | $54.15M | +2.3% | +$1.21M | ||
| 2015 | $52.94M | +32.9% | +$13.12M | ||
| 2014 | $39.82M | +50.6% | +$13.38M | ||
| 2013 | $26.44M | +23.1% | +$4.96M | ||
| 2012 | $21.48M | +12.1% | +$2.32M | ||
| 2011 | $19.16M | +19.2% | +$3.09M | ||
| 2010 | $16.07M | +6.5% | +$984,000 | ||
| 2009 | $15.09M | -14.9% | -$2.65M | ||
| 2008 | $17.73M | +45.2% | +$5.52M | ||
| 2007 | $12.21M | +37.0% | +$3.30M | ||
| 2006 | $8.91M | +13198.5% | +$8.84M | ||
| 2005 | $67,000 | -98.7% | -$5.02M | ||
| 2004 | $5.09M | -60.2% | -$7.71M | ||
| 2003 | $12.80M | -42.4% | -$9.41M | ||
| 2002 | $22.21M | — | +$22.21M | ||
| 2001 | $0 | — | $0 | ||
| 2000 | $0 | — | $0 | ||
| 1999 | $0 | — | — |
Stock-Based Compensation values are taken from Align Technology's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Align Technology (ALGN) reported stock-based compensation of $0 – plunged 100.0% year-over-year.
Align Technology stock-based compensation compound annual growth for the 2020–2025 (5 years) window is -100.0%, with a net decline across the window.
The dataset's maximum stock-based compensation sits at $173.70M (2024); the minimum reading of $0 dates to 1999.
Align Technology (ALGN) sits 5th of 8 Healthcare peers we track on this metric, against a peer median of $313.00M.
Align Technology Stock-Based Compensation by Year
Align Technology Stock-Based Compensation 2025: $0
Align Technology stock-based compensation in 2025 was $0, plunged 100.0% below 2024.
Align Technology Stock-Based Compensation 2024: $173.70M
Align Technology stock-based compensation in 2024 was $173.70M, grew 12.8% from 2023. This figure represents the highest annual value in the available history.
Align Technology Stock-Based Compensation 2023: $154.03M
Align Technology stock-based compensation in 2023 was $154.03M, grew 15.5% from 2022.
Align Technology Stock-Based Compensation 2022: $133.37M
Align Technology stock-based compensation in 2022 was $133.37M, grew 16.6% from 2021.
Align Technology Stock-Based Compensation 2021: $114.34M
Align Technology stock-based compensation in 2021 was $114.34M.
See more financial history for Align Technology (ALGN).
Sector peers — Stock-Based Compensation
Companies in the same sector as Align Technology, ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $1.35B | Healthcare |
| UnitedHealth Group (UNH) | $971.00M | Healthcare |
| AbbVie (ABBV) | $955.00M | Healthcare |
| Eli Lilly (LLY) | $626.00M | Healthcare |
| Merck & Co. (MRK) | $0 | Healthcare |
| AstraZeneca (AZN) | $0 | Healthcare |
| Novo Nordisk (NVO) | $0 | Healthcare |
| Amgen (AMGN) | $0 | Healthcare |
Frequently asked questions
What is Align Technology's stock-based compensation?
Latest reported stock-based compensation for Align Technology (ALGN) is $271.79M (period ending March 31, 2026).
How has Align Technology stock-based compensation changed year-over-year?
Align Technology (ALGN) stock-based compensation changed -100.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Align Technology stock-based compensation?
Align Technology (ALGN) stock-based compensation compound annual growth rate is -100.0% over the most recent 5 years available.
When did Align Technology stock-based compensation hit its highest annual value?
Align Technology stock-based compensation reached its highest annual value of $173.70M in 2024.
What was Align Technology stock-based compensation in 2024?
Align Technology (ALGN) stock-based compensation in 2024 was $173.70M.
What was Align Technology stock-based compensation in 2025?
Align Technology (ALGN) stock-based compensation in 2025 was $0.
ALGN Key Financials
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
ALGN Overview
Company profile, financial tools, and key metrics
ALGN Revenue Counter
Earns $129.88 every second. See per minute, hour, and day.
ALGN Earnings Counter
Earns $13.63 per second net profit. See per minute, hour, and day.
ALGN Economic Scale
Exceeds Faroe Islands's GDP. Compare with world economies.
ALGN What If Invested
What if you had invested $1,000? See historical returns from any date.
ALGN How It Makes Money
Discover visual breakdown of $4.10B in revenue — where it comes from and where it goes.
ALGN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ALGN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ALGN Daily Price Character
Explosive · 49.8% historical win rate (green days). Streaks & record days.
ALGN Buybacks
1.80% TTM buyback yield. Shareholder yield & SBC comparison.